Introduction
After activation by antigen-presenting cells (APCs), naive, antigen-specific CD4 + T cells differentiate into effector T cells. More than two decades ago, Coffman and Mosman (1) first discovered the heterogeneity of effector T cells, which were then named as T-helper 1 (Th1) or Th2 cells. Th1 and Th2 cells are differentially induced and regulate immunity against intracellular and extracellular pathogens, respectively, as well as immunopathologies such as autoimmunity and allergy. The Th1/Th2 dichotomy dominated the field of immune regulation until 7 years ago when IL-17-expressing T cells were proposed to be a third lineage of helper T cells (2, 3) . Th cell differentiation is instructed by distinct environmental cytokines, which signals through signal transducer and activator of transcription (STAT) or other inducible but generally ubiquitous transcription factors. These factors then upregulate the expression of lineage-specific transcription factors, which function not only to promote its own lineage differentiation but also to inhibit the alternate differentiation pathways. For example, interferon-c (IFN-c)/interleukin-12 (IL-12) through STAT1/STAT4 regulates the transcription of T-bet in Th1 cells. IL-4 signals through STAT6 to induce the expression of GATA3 in Th2 cells. IL-6 and IL-21 act through STAT3, which functions to upregulate the expression of two Th17-specific orphan nuclear receptors, ROR-c and ROR-a, that ultimately determine Th17 cell terminal differentiation (4) . There are extensive cross-regulations of lineage-determining transcription factors. Moreover, there is growing evidence that Th cell lineage commitment can be plastic in certain circumstances.
T-follicular helper (Tfh) cells, originally characterized by their CXCR5 expression, provide essential help for B-cell affinity maturation, class switch recombination, and plasma and memory B-cell generation within the germinal center (GC) (5-9). Many molecules including programmed death-1, inducible costimulator (ICOS), SLAM adapter protein, B and T-lymphocyte attenuator (BTLA), and IL-21 are highly expressed in Tfh cells (7) and have been used to characterize Tfh cells. Recently, we and other groups identified that Bcl6 plays an obligatory role in programing Tfh differentiation and GC reactions (10) (11) (12) . Bcl6 deficiency in CD4 + T cells results in a failure in the generation of Tfh cells and GC responses in vivo, whereas ectopic expression of Bcl6 drives Tfh cell development (10) (11) (12) . These studies on Bcl6 support Tfh cells as a unique T-cell lineage.
Since the pioneering work on Bcl6, increased numbers of factors have been found to regulate Tfh generation. In addition, Tfh developmental pathway has been characterized by using Bcl6 antibody staining or reporter mice. Here, we cover the existing literature on the transcriptional mechanism underlying Tfh differentiation, discuss the dynamic process of Tfh generation, and highlight possible future directions.
Transcriptional factors

Differentiation of naive CD4
+ T cells into different cell lineages is determined by cytokine signaling and subsequent activation of specific transcription factors. For Tfh cell differentiation, it has been shown that neither Th1-(STAT4, Tbet) nor Th2-determining (STAT6, GATA3) transcription factors are required (13) . Despite that both Th17 and Tfh lineages require IL-6/IL-21 and STAT3, Tfh development does not require Th17 transcriptional factors (ROR-a and ROR-c). Instead, Bcl6 serves as the specific transcriptional regulator for Tfh differentiation (7).
STATs
STAT-mediated cytokine signaling pathways are important regulators of T-helper cell development. It has been shown that IL-21 is induced in T cells by IL-6 in a STAT3-dependent manner and is important for Th17 development (14) . In addition, IL-21 has been reported to be important for Tfh differentiation (13 The physiological activator of STAT5 to restrict Tfh generation is likely IL-2. We showed that inhibition of IL-2 greatly enhanced IL-6-driven Tfh differentiation in vitro (18) . Moreover, in a recent study using influenza infection model, Ballesteros-Tato et al. (19) showed that in vivo administration of recombinant IL-2 impaired Tfh cell generation, resulting in a reduction of GCs and long-lived antibody responses, while Il2ra
À/À CD4 + T cells are more prone to become Tfh cells.
Bcl6
The B-cell lymphoma 6 (Bcl6) transcription factor is selectively expressed by mouse and human Tfh cells (20, 21) . Bcl6 was previously shown to be inhibitory in Th2 responses by blocking STAT6 binding to DNA (22, 23) , and Bcl6-deficient mice developed multi-organ inflammatory diseases, enhanced IgE production, and defective GC reaction (24) . However, it was not clear whether the GC defect in these mice is caused by lack of proper T and/or B-cell function because GC B cells also express Bcl6 (25) . Expression of Bcl6 at mRNA level can be moderately upregulated by IL-6 or IL-21 in vitro, and overexpression of Bcl6 promotes the mRNA expression of several Tfhassociated genes in the absence of exogenous cytokines (10) . Interestingly, IL-21 expression was not upregulated by Bcl6 overexpression. Bcl6 expression was not required for the development of Th1, Th2, or Th17 cells, and in fact, overexpression of Bcl6 repressed the production of Th1, Th2, and Th17 cytokines (10) . Bcl6 function appears to be dependent on binding to DNA (10). Yu et al. (12) found that Bcl6 binds to the promoters for the transcriptional regulators T-bet and ROR-c, which determine Th1 and Th17 cell development, respectively, resulting in the repression of IFN-c and IL-17 production. Furthermore, Bcl6 also suppressed the expression of many microRNAs that are thought to control the Tfh generation, including miR-17-92, which repressed CXCR5 expression (12) . Thus, Bcl6 regulates Tfh development through repression of microRNAs and Th1, Th2, and Th17 lineage-specific transcription factors. Bcl6 deficiency in T cells resulted in impaired Tfh development in vitro and in vivo, and Bcl6 expression in both B and T cells is required for germinal canter reactions (10) (11) (12) . Interestingly, Bcl6 repressor, B-lymphocyte-induced maturation protein-1 (Blimp1), was significantly reduced in Tfh cells compared with non-Tfh CD4 + T cells (11 (30, 31) . In addition, Batf-IRF interaction is found to promote dendritic cell (DC) development (32) . At this stage, whether Batf-Jun-IRF4 interaction is required for Tfh cells and their interaction with STAT/Bcl6 factors remains to be determined.
IRF4
Mammalian interferon regulatory factor (IRF) family members play multiple roles within and beyond the immune system (33, 34) . Many of IRF members are expressed in T cells and play important roles in regulating T-cell differentiation (33) . IRF4, a weak DNA binder due to its C-terminal auto-inhibitory domain, is restricted to immune cells in its expression (33, 35) . For IRF4 to execute transcriptional regulation function, it needs cofactors for stable binding with chromatin (30) . In B cells, the binding of PU.1 or related factor SPIB with DNA facilitates recruitment of IRF4 into ETS-IRF composite element (5′-GGAAnnGAAA-3′) and regulates light chain expression (35, 36 (37) , due to a T-cell-intrinsic defect (38) . Furthermore, as mentioned above, IRF4 can interact with Batf-Jun complex in controlling transcriptional regulation (30, 31) . Given the functional importance of Batf-Jun complex in immune system and general impairment caused by IRF4 deficiency in Th1 (39), Th2 (39-42), Th9 (43), Th17 (44, 45) , and Tfh (37, 46) differentiation, the mechanism of how Batf-Jun and/or IRF4 controls T-cell function awaits further evaluation.
c-Maf
The cellular homolog of avian viral V-maf gene (c-Maf) belongs to the AP-1 family, containing basic region and leucine zipper domains (47). C-Maf was initially found to be selectively expressed in Th2 cells to enhance IL-4 production, but not other Th2-related cytokines (47, 48) . In a recent study, Maf À/À chimeric mice exhibited defective Tfh cell differentiation in vivo (49) . Investigators have indicated that because IL-4 and IL-21 are major products of Tfh cells (7, (50) (51) (52) (53) , Tfh cell impairment in the absence of c-Maf is due to defective induction or maintenance of IL-4 and IL-21 in an ICOS-dependent manner (49) . Also, c-Maf is shown to be able to regulate IL-21 in Th17 and IL-4 in Th2 cells (47) (48) (49) . IL-21 is an autocrine growth factor for differentiated Th17 cell expression (14, 54) . In Th17 cells, c-Maf is able to sustain Th17 cells through maintaining IL-21 expression (49). However, in Tfh cells, c-Maf interacts with NFAT and JunB to regulate IL-4 expression (48), which might provide explanations for Gata3-independent IL-4 induction (55).
Current understanding of Tfh development
As Bcl6 was shown as the master regulator of Tfh cells, considerable studies have been focusing on measurement of Bcl6 expression during Tfh differentiation (56) (57) (58) (59) . In an acute lymphocytic choriomeningitis virus (LCMV) infection model, Choi et al. (58) showed that Bcl6 induction occurs as early as second cell division of antigen-specific CD4 + T cell following DC priming. T cells with enhanced Bcl6 expression exhibited CXCR5 expression, but not CD25 or Blimp1 expression (58) , suggesting an early separation of Tfh and non-Tfh lineages. In a recent work, Kitano and colleagues (57) developed a Bcl6-YFP reporter mouse via fusing Bcl6 with YFP and found that Bcl6-YFP was initially upregulated together with CXCR5 on all T cells as early as day 2 following immunization, peaked at day 3, and then was subsequently downregulated. Through flow cytometry analysis, this pattern of Tfh differentiation was also observed in mice transferred with antigen-specific T cell and B cells (56) as well as in the LCMV-infected mouse model (58) . Furthermore, Baumjohann et al. (59) specified two waves of Bcl6 expression during Tfh cell differentiation: Bcl6 expression was upregulated in all divided cells as early as first division after CD4 + T-cell activation; a second wave occurred by the fifth cell division. The above-cited results support that DC priming can induce Bcl6 expression (60) . Because Bcl6 is a determining factor in Tfh cell differentiation, it was favored that DCderived signals determine Tfh differentiation (60) . The questions arise as to how DCs orchestrate Tfh versus nonTfh polarization. A number of studies have shown that DC can promote Bcl6 expression through multiple mechanisms including high-affinity TCR signal (61, 62) , ICOS ligand (63, 64), IL-6 (10, 65), and IL-12 (66) . However, none of above-mentioned factors is unique for Tfh generation; they may work in concert to promote Tfh development, the precise mechanism of which needs further investigation.
In our recent study, by using a Bcl6-IRES-RFP mouse in which RFP expression can faithfully represent Bcl6 protein expression without compromising Bcl6 function, we remeasured the dynamic expression of Bcl6 and CXCR5 during Tfh differentiation in an immunization system (67). Our results revealed that, from day 2 to day 7, Bcl6 expression was gradually upregulated. Notably, CXCR5 expression does not follow the same kinetics: the expression of CXCR5 was rapidly increased at day 2 or 3 and maintained at high level in activated T cells, suggesting Bcl6 is not involved in initiating CXCR5 expression (67) . Indeed, this hypothesis is confirmed by two separate experiments in which Bcl6 deficiency or overexpression did not affect the initiation of CXCR5 expression (67, 68) .
At an early stage of Tfh development, when T cells upregulate CXCR5, but not Bcl6, some of the activated T cells upregulate the expression of Tfh genes, while simultaneously expressing Th1, Th2, and Th17 cell-associated genes (67) . These precursor Tfh cells can be further matured into CXCR5 hi
Bcl6
hi Tfh cells with the help of cognate B cells (7, 67 (13, 72) . In addition, Th1 and Th2 cells generated in vitro can further develop into Tfh cells in vivo after adoptive transfer, supporting the plasticity of T-effector cells during early stages of T-cell differentiation. Therefore, our results favor a somewhat different model (Fig. 1) , in which Bcl6-independent CXCR5 expression guides activated T cells to migrate to interfollicular regions, the subsequent T-B cell interactions at B-T borders instruct further Tfh cell commitment via upregulating or sustaining the expression of Bcl6. Concomitantly, the gradually increased Bcl6 expression acts together with multiple transcriptional factors to specify and stabilize Tfh cells, resulting in downregulation of Th1, Th2, and Th17 cell-associated genes.
Beyond the important role of Bcl6 in programming Tfh cell commitment, it also determines the fate of CXCR5 hi
hi Tfh cells after the effector phase (67) . Several recent studies have indicated that CXCR5 + T cells are able to survive the contraction phase in the presence of persistent deports of peptidemajor histocompatibility complex class II after the primary immune response and eventually become the long-lived memory compartment with diverse characteristics (62, 73, 74) . Actually, the usage of IL-21-YFP and Bcl6-IRES-RFP reporter system provided direct evidence that the transition from effector Tfh to memory Tfh cells could occur in the absence of antigen (50, 67 
